Comparing the rate of immunotherapy treatment change due to toxicity by sex
Abstract Background Immuno‐oncology therapy (IO) is associated with a variety of treatment‐related toxicities. However, the impact of toxicity on the treatment discontinuation rate between males and females is unknown. We hypothesized that immune‐related adverse events would lead to more frequent tr...
Main Authors: | Kevin J. Chua, Shane Kronstedt, Alain Kaldany, Arnav Srivastava, Sai Krishnaraya Doppalapudi, Hao Liu, Ahmad A. Tarhini, Margaret Gatti‐Mays, Elizabeth Gaughan, Siwen Hu‐Lieskovan, Raid Aljumaily, Kenneth Nepple, Bryan Schneider, Joshua Sterling, Eric A. Singer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.1932 |
Similar Items
-
Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
by: Sai Krishnaraya Doppalapudi, et al.
Published: (2021-08-01) -
New Paradigms for Cytoreductive Nephrectomy
by: Benjamin J. Lichtbroun, et al.
Published: (2022-05-01) -
Does Time to Adjuvant Chemotherapy after Radical Cystectomy Affect Survival in Muscle Invasive Bladder Cancer? A Systematic Review
by: Shane Kronstedt, et al.
Published: (2022-11-01) -
The use of blue-light cystoscopy in the detection and surveillance of nonmuscle invasive bladder cancer
by: Ellen M. Cahill, et al.
Published: (2022-09-01) -
Side-to-side versus end-to-side ileocolic anastomosis in right-sided colectomies: A cohort control study
by: Snow Yunni Lin, et al.
Published: (2022-01-01)